神经退行性疾病的抗衰老策略:从机制到临床进展
Qiu Jiang1,2, Jie Liu1,2, Shan Huang1,2
1Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China.
Signal transduction and targeted therapy
|March 10, 2025
概括
全球老龄化增加了神经退行性疾病,如阿尔茨海默病 (AD). 建议采用整体的抗衰老方法,以及特定疾病的治疗方法,以对抗神经退行和认知衰退.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 病理学 病理学 病理学
背景情况:
- 全球人口老龄化与神经退行性疾病和痴呆症,包括阿尔茨海默病 (AD) 的发病率上升有关.
- 目前神经退行性疾病的治疗策略提供了有限的临床益处,突出了需要新的治疗模式.
- 老龄化被确定为神经退行性疾病及其伴随性疾病 (如血管病理) 的主要危险因素.
研究的目的:
- 研究衰老在神经退行性疾病发展中的复杂作用.
- 将大脑概念化为一个复杂的系统网络中的中心组件,受外围器官和组织的影响.
- 提出一个整体的框架,以理解和解决神经退行症在系统衰老的背景下.
主要方法:
- 文献综述和系统生物学方法来分析衰老对大脑功能和神经退行症的影响.
- 检查大脑作为相互连接的身体系统网络中的核心元素.
- 分析老龄化过程中的系统性恶化如何影响大脑对神经退行过程的脆弱性.
主要成果:
- 老龄化导致整个身体的结构和功能逐渐下降,损害了适应性反应.
- 这种系统性恶化增加了对神经退行性疾病和认知障碍的易感性.
- 大脑的健康与生物体的整体生理状态密切相关.
结论:
- 神经退行性疾病和痴呆症应该通过整体的抗衰老和复苏战略来解决.
- 这种方法应该与针对AD等疾病的特定病原机制的干预措施相结合.
- 一个综合的,系统的观点为预防,停止或减缓神经退行和认知衰退提供了一个有希望的途径.
相关概念视频
Alzheimer's Disease: Overview
412
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
412
Alzheimer's Disease: Treatment
142
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
142
Parkinson's Disease: Overview
415
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
415
Aging
34
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
34
Parkinson's Disease: Treatment
178
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
178
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K


